Journal of Otolaryngology and Ophthalmology of Shandong University ›› 2019, Vol. 33 ›› Issue (3): 9-13.doi: 10.6040/j.issn.1673-3770.1.2018.043

• Invited Review • Previous Articles     Next Articles

Endotypes and precision medicine in chronic sinusitis treatment

Huabin LI(),Yuting LAI,Wenxiu JIANG   

  1. Department of Otolaryngology, Eye and ENT Hospital, Fudan University, Shanghai 200031, China
  • Received:2018-12-03 Revised:2019-04-11 Online:2019-05-20 Published:2019-08-07
  • Contact: Huabin LI E-mail:noseli@163.com

RichHTML

20

PDF (PC)

613

Abstract:

Chronic rhinosinusitis (CRS) is a common otolaryngologic disease, with a complex intrinsic pathological mechanism. Traditional medicine and surgery do not fully treat CRS. In recent years, precision medicine has been used to develop new biological agents to treat CRS based on its phenotype. This article reviews the current endotypes of CRS that have therapeutic significance, including type II inflammatory, eosinophilic, epithelial barrier function, and epithelium-derived cytokine endotypes, and those that are still in the theoretical stage of research, including the non-type II inflammatory phenotype and tissue remodeling.

Key words: Chronic rhinosinusitis, Pathogenesis, Endotype, Precision medicine, Biologic products

CLC Number: 

  • R765.41
1 FokkensWJ, LundVJ, MullolJ, et al. EPOS 2012: European position paper on rhinosinusitis and nasal polyps 2012. A summary for otorhinolaryngologists[J]. Rhin, 2012, 50(1): 1-12. doi:10.4193/rhino50e2.
doi: 10.4193/rhino50e2
2 KucuksezerUC, OzdemirC, AkdisM, et al. Chronic rhinosinusitis: pathogenesis, therapy options, and more[J]. Expert Opinion on Pharmacotherapy, 2018, 19(16): 1805-1815. doi:10.1080/14656566.2018.1527904.
doi: 10.1080/14656566.2018.1527904
3 TomassenP, VandeplasG, van ZeleT, et al. Inflammatory endotypes of chronic rhinosinusitis based on cluster analysis of biomarkers[J]. Journal of Allergy and Clinical Immunology, 2016, 137(5): 1449-1456.e4. doi:10.1016/j.jaci.2015.12.1324.
doi: 10.1016/j.jaci.2015.12.1324
4 CollinsFS, VarmusH. A new initiative on precision medicine[J]. N Engl J Med, 2015, 372(9): 793-795. doi:10.1056/nejmp1500523.
doi: 10.1056/nejmp1500523
5 BachertC, ZhangN, HellingsPW, et al. Endotype-driven care pathways in patients with chronic rhinosinusitis[J]. Journal of Allergy and Clinical Immunology, 2018, 141(5): 1543-1551. doi:10.1016/j.jaci.2018.03.004.
doi: 10.1016/j.jaci.2018.03.004
6 MorrisseyDK, BassiouniA, PsaltisAJ, et al. Outcomes of modified endoscopic Lothrop in aspirin-exacerbated respiratory disease with nasal polyposis[J]. Int Forum Allergy Rhinol, 2016, 6(8): 820-825. doi:10.1002/alr.21739.
doi: 10.1002/alr.21739
7 TurnerJH, ChandraRK, LiP, et al. Identification of clinically relevant chronic rhinosinusitis endotypes using cluster analysis of mucus cytokines[J]. Journal of Allergy and Clinical Immunology, 2018, 141(5): 1895-1897.e7. doi:10.1016/j.jaci.2018.02.002.
doi: 10.1016/j.jaci.2018.02.002
8 BachertC, MannentL, NaclerioRM, et al. Effect of subcutaneous dupilumab on nasal polyp burden in patients with chronic sinusitis and nasal polyposis[J]. JAMA, 2016, 315(5): 469. doi:10.1001/jama.2015.19330.
doi: 10.1001/jama.2015.19330
9 BachertC, ZhangL, GevaertP. Current and future treatment options for adult chronic rhinosinusitis: Focus on nasal polyposis[J]. Journal of Allergy and Clinical Immunology, 2015, 136(6): 1431-1440. doi:10.1016/j.jaci. 2015.10.010.
doi: 10.1016/j.jaci. 2015.10.010
10 PettipherR, HunterMG, PerkinsCM, et al. Heightened response of eosinophilic asthmatic patients to the CRTH2 antagonist OC000459[J]. Allergy, 2014, 69(9): 1223-1232. doi:10.1111/all.12451.
doi: 10.1111/all.12451
11 BachertC, ZhangN, HoltappelsG, et al. Presence of IL-5 protein and IgE antibodies to staphylococcal enterotoxins in nasal polyps is associated with comorbid asthma[J]. Journal of Allergy and Clinical Immunology, 2010, 126(5): 962-968.e6. doi:10.1016/j.jaci.2010.07.007.
doi: 10.1016/j.jaci.2010.07.007
12 HeckS, NguyenJ, LeDD, et al. Pharmacological therapy of bronchial asthma: the role of biologicals[J]. Int Arch Allergy Immunol, 2015, 168(4): 241-252. doi:10.1159/000443930.
doi: 10.1159/000443930
13 WangXD, ZhangN, BoMY, et al. Diversity of T H cytokine profiles in patients with chronic rhinosinusitis: A multicenter study in Europe, Asia, and Oceania[J]. Journal of Allergy and Clinical Immunology, 2016, 138(5): 1344-1353. doi:10.1016/j.jaci.2016.05.041.
doi: 10.1016/j.jaci.2016.05.041
14 KimDW, KimDK, JoA, et al. Age-related decline of neutrophilic inflammation is associated with better postoperative prognosis in non-eosinophilic nasal polyps[J]. PLoS One, 2016, 11(2): e0148442. doi:10.1371/journal.pone.0148442.
doi: 10.1371/journal.pone.0148442
15 KimDK, JinHR, EunKM, et al. Non-eosinophilic nasal polyps shows increased epithelial proliferation and localized disease pattern in the early stage[J]. PLoS One, 2015, 10(10): e0139945. doi:10.1371/journal.pone. 0139945.
doi: 10.1371/journal.pone. 0139945
16 ArmJP, BottoliI, SkerjanecA, et al. Pharmacokinetics, pharmacodynamics and safety of QGE031 (ligelizumab), a novel high-affinity anti-IgE antibody, in atopic subjects[J]. Clin Exp Allergy, 2014, 44(11): 1371-1385. doi:10. 1111/cea.12400.
doi: 10. 1111/cea.12400
17 GauvreauGM, HarrisJM, BouletLP, et al. Targeting membrane-expressed IgE B cell receptor with an antibody to the M1 prime epitope reduces IgE production[J]. Science Translational Medicine, 2014, 6(243): 243ra85. doi:10.1126/scitranslmed.3008961.
doi: 10.1126/scitranslmed.3008961
18 van ZeleT, GevaertP, HoltappelsG, et al. Oral steroids and doxycycline: Two different approaches to treat nasal polyps[J]. Journal of Allergy and Clinical Immunology, 2010, 125(5): 1069-1076.e4. doi:10.1016/j.jaci.2010. 02. 020.
doi: 10.1016/j.jaci.2010. 02. 020
19 SoykaMB, WawrzyniakP, EiweggerT, et al. Defective epithelial barrier in chronic rhinosinusitis: The regulation of tight junctions by IFN-γ and IL-4[J]. Journal of Allergy and Clinical Immunology, 2012, 130(5): 1087-1096.e10. doi:10.1016/j.jaci.2012.05.052.
doi: 10.1016/j.jaci.2012.05.052
20 SteelantB, SeysSF, BoeckxstaensG, et al. Restoring airway epithelial barrier dysfunction: a new therapeutic challenge in allergic airway disease[J]. Rhin, 2017, 54(3): 195-205. doi:10.4193/rhin15.376.
doi: 10.4193/rhin15.376
21 SteelantB, FarréR, WawrzyniakP, et al. Impaired barrier function in patients with house dust mite-induced allergic rhinitis is accompanied by decreased occludin and zonula occludens-1 expression[J]. Journal of Allergy and Clinical Immunology, 2016, 137(4): 1043-1053.e5. doi:10.1016/j.jaci.2015.10.050.
doi: 10.1016/j.jaci.2015.10.050
22 GauvreauGM, O'ByrnePM, BouletLP, et al. Effects of an anti-TSLP antibody on allergen-induced asthmatic responses[J]. N Engl J Med, 2014, 370(22): 2102-2110. doi:10.1056/nejmoa1402895.
doi: 10.1056/nejmoa1402895
23 MizutaniN, NabeT, YoshinoS. Interleukin-33 and alveolar macrophages contribute to the mechanisms underlying the exacerbation of IgE-mediated airway inflammation and remodelling in mice[J]. Immunology, 2013, 139(2): 205-218. doi:10.1111/imm.12071.
doi: 10.1111/imm.12071
24 TangW, SmithSG, BeaudinS, et al. IL-25 and IL-25 receptor expression on eosinophils from subjects with allergic asthma[J]. Int Arch Allergy Immunol, 2014, 163(1): 5-10. doi:10.1159/000355331.
doi: 10.1159/000355331
25 LindénA, DahlénB. Interleukin-17 cytokine signalling in patients with asthma[J]. Eur Respir J, 2014, 44(5): 1319-1331. doi:10.1183/09031936.00002314.
doi: 10.1183/09031936.00002314
26 van ZeleT, HoltappelsG, GevaertP, et al. Differences in initial immunoprofiles between recurrent and nonrecurrent chronic rhinosinusitis with nasal polyps[J]. Am J Rhinol Allergy, 2014, 28(3): 192-198. doi:10.2500/ajra. 2014.28.4033.
doi: 10.2500/ajra. 2014.28.4033
27 LiXY, MengJ, QiaoXM, et al. Expression of TGF, matrix metalloproteinases, and tissue inhibitors in Chinese chronic rhinosinusitis[J]. Journal of Allergy and Clinical Immunology, 2010, 125(5): 1061-1068. doi:10.1016/j.jaci.2010.02.023.
doi: 10.1016/j.jaci.2010.02.023
28 KimDY, ChoSH, TakabayashiT, et al. Chronic rhinosinusitis and the coagulation system[J]. Allergy Asthma Immunol Res, 2015, 7(5): 421. doi:10.4168/aair.2015.7. 5.421.
doi: 10.4168/aair.2015.7. 5.421
29 TakabayashiT, KatoA, PetersAT, et al. Excessive fibrin deposition in nasal polyps caused by fibrinolytic impairment through reduction of tissue plasminogen activator expression[J]. Am J Respir Crit Care Med, 2013, 187(1): 49-57. doi:10.1164/rccm.201207-1292oc.
doi: 10.1164/rccm.201207-1292oc
30 TakabayashiT, KatoA, PetersAT, et al. Increased expression of factor XIII-A in patients with chronic rhinosinusitis with nasal polyps[J]. Journal of Allergy and Clinical Immunology, 2013, 132(3): 584-592.e4. doi:10.1016/j.jaci.2013.02.003.
doi: 10.1016/j.jaci.2013.02.003
[1] Meiping LU,Lei CHENG. Current status of genetic research on allergic rhinitis [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2019, 33(3): 36-41.
[2] SUN Ziwen, CUI Hongwei, SUN Xiling, CHEN Chen, ZHANG Lu, HU Zhulin. SUN Ziwen1, CUI Hongwei2, SUN XilingEtiology, pathogenesis, and management of dry eye [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2019, 33(2): 159-166.
[3] Hongmeng YU,Zhuofu LIU,Qi DAI. Endoscopic sinus surgery for chronic sinusitis with asthma [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2019, 33(1): 38-41.
[4] Yu ZHANG,Xicheng SONG. Advances in interaction mechanisms and treatment strategy between chronic rhinosinusitis with nasal polyp and asthma [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2019, 33(1): 49-52.
[5] WANG Yakun, ZHANG Yu, SONG Xicheng. Analysis of pulmonary function and its influencing factors in chronic rhinosinusitis without lower airway disease [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2019, 33(1): 99-102.
[6] WANG Jianwei, ZHANG Yu, SONG Xicheng. Analysis of pulmonary function of patients who developed chronic rhinosinusitis with nasal polyps and asthma [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2019, 33(1): 103-108.
[7] SONG Xiaoyu, ZHANG Yu, LI Chenglin, SONG Xicheng. Enhanced recovery after surgery for the treatment of chronic rhinosinusitis with nasal polyps [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2018, 32(5): 9-12.
[8] HUANG Yuan, BA Luo, LI Bo, YU Wenxing, YANG Fangli, DU Jintao. Transcription factor NKX2-1 regulates eosinophilic inflammation in chronic rhinosinusitis with nasal polyps [J]. J Otolaryngol Ophthalmol Shandong Univ, 2018, 32(4): 17-23.
[9] LOU Hongfei, WANG Chengshuo. Progress in classification of chronic sinusitis [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2018, 32(3): 10-13.
[10] GONG Qi, ZHANG Jie, ZHAO Pingping. Effect of nasal dilation on quality of sleep in adult patients with chronic rhinosinusitis and [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2018, 32(2): 52-55.
[11] LIN Xing, LIN Zongtong, SHEN Ling.. Outcomes of sinus balloon catheter dilation in treatment of pediatric chronic rhinosinusitis: a systematic review and meta-analysis. [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2017, 31(6): 79-86.
[12] LUN Jie, ZHANG Ya′nan. Analysis on the factors related to the recurrence of chronic rhinosinusitis with nasal polyps. [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2017, 31(3): 80-83.
[13] . Progress of tight junctions and chronic rhinosinusitis. [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2017, 31(2): 112-115.
[14] ZHANG Ruxin. Prospect and progress of allergic rhinitis. [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2016, 30(4): 3-6.
[15] SU Yi, XIE Jinghua, PAN Xiaoli, ZENG Guoqing. Efficacy and associated factors of endoscopic sinus surgery on patients with chronic rhinosinusitis with or without nasal polyps. [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2016, 30(4): 86-89.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
[1] . [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2006, 20(1): 84 -87 .
[2] . [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2006, 20(2): 116 -118 .
[3] CHEN Wen-wen . [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2006, 20(5): 472 -472 .
[4] ZHOU Bin,LI Bin . Endoscopic sinus surgery for 75 patients with chronic sinusitis and nasal polyps[J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2006, 20(1): 24 -26 .
[5] YANG Changliang,HUANG Zhiwu,YAO Hangqi,ZHU Yong,SNU Yi . Study on auditory brainstem response[J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2006, 20(1): 9 -13 .
[6] . [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2006, 20(1): 89 -89 .
[7] NIU Shanli,CHAI Maowen,LI Zhenxiu . Endoscopic rhinoplasty of inferior turbinate in 60 patients with chronic hypertrophic rhinitis[J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2006, 20(1): 16 -18 .
[8] LIU Da-yu,PAN Xin-liang,LEI Da-peng,ZHANG Li-qiang,LUAN Xin-yong . Surgical treatment for medial wall pyriform sinus cancer[J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2007, 21(1): 8 -11 .
[9] MENG Qing-guo,LU Yong-tian,FAN Xian-liang .

Association of killer cell immunoglobulin-like receptor gene polymorphisms with nasopharyngeal carcinoma

[J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2008, 22(3): 196 -199 .
[10] . [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2008, 22(3): 199 -199 .
Website Copyright: Editorial Office of Journal of Otolaryngology and Ophthalmology of Shandong University
Address: No.27 Shanda South Road, Jinan, Shandong, China. Post code: 250100 Tel: +86-0531-88366912 Email: ebhxb@sdu.edu.cn Supported by Beijing Magtech Co.Ltd